Conducting Effective OOS or OOT Investigations for Unexpected Results from the BET Assay



Similar documents
Dedicated and calibrated pipettes can reduce variability. The Most Expensive Test is a Retest By Ruth Noe, UK and Ireland Sales Manager

PROCEDURES FOR HANDLING OOS RESULTS

WinKQCL 5 Endotoxin Detection and Analysis Software We Analyze Endotoxin Data Every Day

ASSURING THE QUALITY OF TEST RESULTS

To avoid potential inspection

1 Quality Assurance and Quality Control Project Plan

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS

3.4 TEST FOR BACTERIAL ENDOTOXINS. Final text for revision of The International Pharmacopoeia

QbD Approach to Assay Development and Method Validation

Assay Qualification Template for Host Cell Protein ELISA

The Global Fund experience on malaria RDTs. Rationale to enhance harmonization

Design of Experiments for Analytical Method Development and Validation

LAB ID and/or LABORATORY NAME: ASSESSOR NAME: CONTINUOUS RADON MONITOR (CRM) by Proportional Counting. Method Number: ELAP method code 7037

Guidance for Industry

Pharma&Biotech. Endotoxin Challenge Vials Endotoxin Indicator for Depyrogenation. Translated versions available at

Workflow System for Paperless Air Monitoring Powered by MODA. Presented by

Assay Development and Method Validation Essentials

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

APPENDIX 7-B SUGGESTED OUTLINE OF A QUALITY ASSURANCE PROJECT PLAN

FRC Risk Reporting Requirements Working Party Case Study (Pharmaceutical Industry)

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

American Association for Laboratory Accreditation

LALreview. The Continual Evolution of Software EDITOR S COLUMN

Quality Assurance/Quality Control in Acid Deposition Monitoring

APPENDIX N. Data Validation Using Data Descriptors

Evaluating Laboratory Data. Tom Frick Environmental Assessment Section Bureau of Laboratories

Implementing New USP Chapters for Analytical Method Validation

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Sandoz Private Limited 10/22/15

The FDA recently announced a significant

Ecology Quality Assurance Glossary

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Control Charts and Trend Analysis for ISO Speakers: New York State Food Laboratory s Quality Assurance Team

Validation and Calibration. Definitions and Terminology


Improvement in QC Environmental Monitoring Processes with Paperless Data Capture System

Application Sheet for Rivaroxaban (Xarelto ) Standard Range with. BIOPHEN Heparin LRT (#221011/221013) RUO

Method Validation/Verification. CAP/CLIA regulated methods at Texas Department of State Health Services Laboratory

QA GLP audits. Alain Piton. Antipolis,, France.

MIDLAND AREA SOIL SAMPLING MIDLAND, MICHIGAN

New changes to cleanroom & clean air device classifications: ISO & 2

Individualized Quality Control Plan

TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS

Guidance for Industry

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)

UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE

OOS investigations in a GMP environment

ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology. Step 5

Cold Agglutination Titer detecting Cold Reacting Antibodies

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

Deviation and Out of Specification Handling

V1.0 - Eurojuris ISO 9001:2008 Certified

Data Quality. Tips for getting it, keeping it, proving it! Central Coast Ambient Monitoring Program

Assay Laboratory Quality Assurance

XYZ Medica Inc. Change Management

Data Management Implementation Plan

MODA Solution Automated QC Microbiology Processes for Regulated Manufacturing

Technical Guidance Manual for the Implementation of the Hawai`i State Contingency Plan. Interim Final SECTION 10

Welcome to Implementing Inquirybased Microbial Project. Veronica Ardi, PhD

Audits must be conducted with due concern for employee safety and environmental protection.

IMPURITIES IN NEW DRUG PRODUCTS

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION

Laboratory Information Management System

MODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS

The Study Site Master File and Essential Documents

1. PURPOSE To provide a written procedure for laboratory proficiency testing requirements and reporting.

Guidance for Industry: Starting Material Supplier Management

Like-For-Like Changes: Is Validation Testing Needed? Validation Case Study #7

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, Oct 2009

ILLINOIS DEPARTMENT OF CENTRAL MANAGEMENT SERVICES CLASS SPECIFICATION STATE POLICE EVIDENCE TECHNICIAN SERIES

Thermo Scientific Dionex Chromeleon 7 Chromatography Data System Software

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers

Applying Statistics Recommended by Regulatory Documents

Triangle Compounding 11/2/15

Diagnosis of HIV-1 Infection. Estelle Piwowar-Manning HPTN Central Laboratory The Johns Hopkins University

QUALITY ASSURANCE / QUALITY CONTROL POLICY BREG SOIL AND WATER QUALITY LABORATORY UNIVERSITY OF DELAWARE

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

BUSINESS PROCESS DOCUMENT. e-bulk Interface. Date: 6 January 2014 Version: 4.0

Building Credibility: Quality Assurance & Quality Control for Volunteer Monitoring Programs

Best Practice In A Change Management System

2016 > Emcure Pharmaceuticals Limited 3/3/16

FDA Inspection Observations The FDA 483 and Beyond. Objectives

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

QUALITY RISK MANAGEMENT (QRM): A REVIEW

Particle Monitoring Requirements in Pharmaceutical Cleanrooms

Current methods: late results (2 to 3 days) contamination spread in the distribution system water consumed

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

Annex 1 WHO good practices for pharmaceutical quality control laboratories

CHAPTER ONE TABLE OF CONTENTS 1.0 INTRODUCTION... 1

ENZYME KINETICS ENZYME-SUBSTRATE PRODUCTS

USING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY

Chemistry 111 Laboratory Experiment 7: Determination of Reaction Stoichiometry and Chemical Equilibrium

Reversed Phase High Presssure Liquid Chromatograhphic Technique for Determination of Sodium Alginate from Oral Suspension

Transcription:

Pharma&Biotech Conducting Effective OOS or OOT Investigations for Unexpected Results from the BET Assay Lonza Cologne GmbH, Cologne / 10 May 2013 Lonza

Dealing with Unexpected Results in Routine Testing In a well controlled aseptic production process, the likelihood of product adulteration by endotoxin should be minimal This means that the vast majority of results generated in the BET should be either below the Endotoxin Release Limit (ERL) for the product or undetectable i.e. below the detection limit of the assay However, unexpected results can and do occur with some frequency in QC laboratories, worldwide 2

FDA Guidelines on OOS & OOT Results OOS (Out of Specification) All suspect results that fall outside the specification or acceptance criteria established in new drug applications, official compendia, or by the manufacturer OOT (Out of Tolerance) Consideration should equally be applied to results which are atypical and could constitute an increased risk Source FDA Guidance for Industry. Investigating Out of Specification (OOS) Test Results for Pharmaceutical Production. http://www.fda.gov/cder/guidance/index.htm 3

Initial Assessment There should be an objective and timely assessment to: Establish likelihood of laboratory error OR Confirm there is an indication of manufacturing process / product problems Assess significance of the result in overall QA program The process for making the decision on these key questions must be documented in an approved SOP 4

BET Assay Assessment Flow Chart Assay criteria met %CV standard correlation Y-INT/slope Blank reaction < Lowest standard Sample criteria met %CV standard Single well reaction PPC recovery Endotoxin recovery within limits Test passes Assay criteria NOT met Assay invalid Sample criteria NOT met Sample invalid Result OOS Test fails Retest whole assay Retest invalid samples OOS investigation Not OOS but INVESTIGATE if REPEATED 5

If an OOS Investigation Is Merited Report suspect result to QA/Regulatory for assessment Notify production of need to investigate process An investigation team should be formed Start a documented investigation process, as soon as possible Make preliminary assessment of effects Inform customer services / production of potential consequences 6

Can the Result Be Attributed to Laboratory Error? Supporting historical data with trend analysis will help Justify the decision making process Suggest Corrective And Preventative Actions (CAPA) Working with paper-based reports or excel spreadsheets can be cumbersome As kinetic BET assays generate large volumes of data, a database approach is recommended with Structured Query Language capability 7

Laboratory Error Potential Causes Sample Correct sample? Sampled correctly Condition? Contamination during dilution Retest originals Retest new samples Negative controls ok? OOS result Correct procedure? Training records Any unusual events during testing? Test equipment Test reagents Test consumables Contamination in other tests? 8

A Logical Approach Can Focus the Investigation When investigating potential laboratory error, use logic to narrow the field of investigation I usually classify issues with kinetic assays into one of three types Likely to cause individual well variations, i.e. one well in error in a pair Likely to cause multiple replicate errors, i.e. duplicate wells are in error Likely to cause multiple well variations (all or several wells on the same plate in error) Similarly, you can identify factors that are likely to only affect the standard curve or only likely to affect sample results. Doing this will narrow the field of search, when asking questions of the database. 9

PPC Out-Of-Trend Situation The following example illustrates the ease and efficiency of investigating OOS or OOT results using trend analysis: Company XYZ makes an antibiotic Polymegacillin PPC recovery percentages are normally consistent but recent assays show a sharp upward trend, with OOS & OOT results Endotoxin results for the unspiked samples appear normal and follow previous trend 10

Potential Sources of Error in PPC Recovery What could be the possible cause(s)? Technician Error? Glucans? Sample contamination? Accessories? Change in product formulation? Plan of action? Data Analysis & Trending using the built-in Trend Analysis module of the WinKQCL Software 11

Query qualifiers used Sharp upward trend for PPC results from assay 31 onwards

Query qualifiers used 5 analysts involved

Query qualifiers used Nearly all OOT PPCs performed by PJONES Faulty technique? Contamination?

Isolate items most likely to be involved e.g. P20 pipettor

Only two P20 units in active use One unit PIP782 only used by technician PJONES

Query qualifiers used P20 with ID 782 is associated with all high PPC values

Query qualifiers used in this case to highlight the evidence Evidence clearly indicates a problem with the P20 unit PIP 782 is the culprit and not technique

Conclusions Use of a SQL-database trending program can help identify the cause of unexpected OOS or OOT results Such a database should be designed to automatically collect this data, as in the case in Lonza s WinKQCL Endotoxin Detection and Analysis Software The ability to cross-examine and trend data using query qualifiers helps to rapidly uncover the source(s) of error Use of such an integral database can save both time and money, whilst providing documentary evidence for decision processes 19

Thank You!